BeOne Medicines Ltd.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONC and other ETFs, options, and stocks.About ONC
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations.
CEOJohn V. Oyler
CEOJohn V. Oyler
Employees12,000
Employees12,000
HeadquartersBasel, Basel-Landschaft (Basle Country)
HeadquartersBasel, Basel-Landschaft (Basle Country)
Founded2010
Founded2010
Employees12,000
Employees12,000
ONC Key Statistics
Market cap45.56B
Market cap45.56B
Price-Earnings ratio66.36
Price-Earnings ratio66.36
Dividend yield—
Dividend yield—
Average volume412.47K
Average volume412.47K
High today—
High today—
Low today—
Low today—
Open price$374.14
Open price$374.14
Volume683.00
Volume683.00
52 Week high$388.66
52 Week high$388.66
52 Week low$253.95
52 Week low$253.95
ONC News
TipRanks 4d
BeOne Medicines Completes Key Sonrotoclax Formulation Study, Trimming Early-Stage RiskBeOne Medicines (ONC) announced an update on their ongoing clinical study. BeOne Medicines is running a Phase 1 study called “A Phase 1, Single-dose, Open-labe...
Analyst ratings
93%
of 30 ratingsBuy
93.3%
Hold
6.7%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.